STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

PALO ALTO VETERANS INSTITUTE FOR RESEARCH: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
PALO ALTO VETERANS INSTITUTE FOR RESEARCH (EIN 77-0207331)
Tax period
2020-10-01 to 2021-09-30
Filed
2022-05-27
IRS object ID
202231479349301253
Schema version
2020v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-05-27T15:44:07-05:00ReturnTs
Tax Period End2021-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN814234542PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BPM LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14200 BOHANNON DRIVE SUITE 250AddressLine1Txt
CityMENLO PARKCityNm
State AbbreviationCAStateAbbreviationCd
ZIP940251021ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN770207331EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PALO ALTO VETERANS INSTITUTE FORBusinessNameLine1Txt
Business Name Line2RESEARCHBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlPALOBusinessNameControlTxt
Phone6502392800PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line13801 MIRANDA AVENUEAddressLine1Txt
CityPALO ALTOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94304ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonELAINE STAATSPersonNm
Person TitleCEOPersonTitleTxt
Phone6502392802PhoneNum
Signature2022-05-24SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstELAINEPersonFirstNm
Person LastSTAATSPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonCAROLYN R AMSTERPreparerPersonNm
PTINP00189994PTIN
Phone6508556800PhoneNum
Preparation2022-05-24PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1PAVIRBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerELAINE STAATSPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line13801 MIRANDA AVENUEAddressLine1Txt
CityPALO ALTOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94304ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$29,467,576GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.PAVIR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1988FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionADVANCING VETERAN AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee273TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$23,851,668PYContributionsGrantsAmt
CY Contributions Grants$24,470,355CYContributionsGrantsAmt
PY Program Service Revenue$5,633,108PYProgramServiceRevenueAmt
CY Program Service Revenue$4,876,898CYProgramServiceRevenueAmt
PY Investment Income$47,815PYInvestmentIncomeAmt
CY Investment Income$16,959CYInvestmentIncomeAmt
PY Other Revenue$40,051PYOtherRevenueAmt
CY Other Revenue$35,800CYOtherRevenueAmt
PY Total Revenue$29,572,642PYTotalRevenueAmt
CY Total Revenue$29,400,012CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$16,710,546PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$16,053,637CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$14,478,372PYOtherExpensesAmt
CY Other Expenses$12,065,304CYOtherExpensesAmt
PY Total Expenses$31,188,918PYTotalExpensesAmt
CY Total Expenses$28,118,941CYTotalExpensesAmt
PY Revenues Less Expenses-$1,616,276PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,281,071CYRevenuesLessExpensesAmt
Total Assets BOY$12,982,406TotalAssetsBOYAmt
Total Assets EOY$15,189,973TotalAssetsEOYAmt
Total Liabilities BOY$6,265,277TotalLiabilitiesBOYAmt
Total Liabilities EOY$7,191,146TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$6,717,129NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$7,998,827NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OPAVIR'S MISSION IS ADVANCING VETERANS AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH. PAVIR WORKS WITH MORE THAN 100 RESEARCHERS AND 215 STAFF TO SUPPORT BASIC SCIENCE AND CLINICAL RESEARCH TO REALIZE ITS MISSION. PAVIR'S RESEARCH SPANS THE INVESTIGATION OF DISEASES IN THE LABORATORY TO TESTING NEW DRUG TREATMENTS AND DEVELOPING IMPROVED MODELS OF HEALTH CARE DELIVERY. IN ADDITION TO A FOCUS ON BASIC SCIENCE AND CLINICAL RESEARCH, PAVIR'S RESEARCH ADDRESSES HEALTH CHALLENGES THAT HAVE BEEN FACED ESPECIALLY BY VETERANS, INCLUDING POST-TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY, GERIATRIC MEDICINE, REHABILITATION, SLEEP AND OTHER VETERANS AND PUBLIC HEALTH DISEASES. PAVIR'S RESEARCHERS HAVE APPOINTMENTS AT THE VA PALO ALTO HEALTH CARE SYSTEM, AND MOST HOLD DUAL APPOINTMENTS AT THE STANFORD UNIVERSITY SCHOOL OF MEDICINEMissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,655,602ExpenseAmt
Revenue$1,655,602RevenueAmt
DescTARGETED STRATEGIES TO ACCELERATE EVIDENCE-BASED PSYCHOTHERAPY (EBP) IMPLEMENTATION IN MILITARY. PRINCIPAL INVESTIGATORS: CRAIG S. ROSEN, PH.D. AND CARMEN P. MCLEAN, PH.D. THIS FOUR-YEAR STUDY, FUNDED BY THE DEPARTMENT OF DEFENSE, IS AIMED AT INCREASING USE OF EVIDENCE-BASED PSYCHOTHERAPIES (THERAPIES PROVEN EFFECTIVE IN RESEARCH) IN CLINICS ON MILITARY BASES. DESPITE EFFORTS TO TRAIN MILITARY PROVIDERS IN EFFECTIVE PSYCHOTHERAPIES FOR POSTTRAUMATIC STRESS DISORDER (PTSD), ONLY A MINORITY OF SERVICE MEMBERS RECEIVE THESE TREATMENTS. THIS TRIAL TESTS WHETHER A TAILORED PROCESS IMPROVEMENT APPROACH (USING A TOOLKIT FOR MATCHING SPECIFIC CHANGE STRATEGIES TO LOCAL BARRIERS) IS MORE EFFECTIVE THAN PROVIDER TRAINING ALONE IN EXPANDING THE PROPORTION OF PATIENTS WHO RECEIVE AN EBP. THE PROJECT, LED BY INVESTIGATORS AT THE NATIONAL CENTER FOR PTSD AND PALO ALTO VETERANS INSTITUTE FOR RESEARCH (PAVIR), INCLUDES COLLABORATORS FROM FIVE UNIVERSITIES AND EIGHT MILITARY TREATMENT FACILITIES. OBJECTIVES: TO TEST IN A STEPPED-WEDGE RANDOMIZED TRIAL WHETHER THE TARGETED ASSESSMENT AND CONTEXT-TAILORED IMPLEMENTATION OF CHANGE STRATEGIES (TACTICS) INCREASES USE OF EVIDENCE-BASED PSYCHOTHERAPY MORE THAN DOES PROVIDER TRAINING ALONE. SECONDARY OUTCOMES INCLUDE EFFECTS OF TACTICS ON AVERAGE IMPROVEMENT IN PTSD SYMPTOMS, AND SATISFACTION WITH THE TACTICS PROCESS. ACCOMPLISHMENTS: ALL STAFF HAVE BEEN HIRED, EIGHT MILITARY CLINICS REPRESENTING ALL SERVICE BRANCHES WERE RECRUITED AND ALL REGULATORY APPROVALS OBTAINED. PROVIDER TRAINING AND THE SUBSEQUENT PROCESS IMPROVEMENT INTERVENTION (TACTICS) HAS BEEN IMPLEMENTED AT ALL STUDY SITES. PROVIDER SURVEY DATA COLLECTION IS COMPLETED. CENTRALIZED EXTRACTION OF STUDY DATA IN COLLABORATION WITH THE DEFENSE HEALTH AGENCY IS ONGOING.POTENTIAL IMPACT: IF EFFECTIVE, TACTICS MAY REPRESENT A SCALABLE APPROACH TO ACCELERATING THE USE OF BEHAVIORAL HEALTH BEST PRACTICES IN MILITARY SETTINGS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$800,160ExpenseAmt
DescNOVEL STRATEGIES TO COMBAT POST-TRAUMATIC OSTEOARTHRITIS (PTOA): GAIT RETRAINING TO REDUCE JOINT LOADING, INFLAMMATION, AND PTOA RISK AKA NOVEL STRATEGIES TO COMBAT POST-TRAUMATIC OSTEOARTHRITIS. PRINCIPAL INVESTIGATORS: CONSTANCE CHU, M.D. AND WILLIAM ROBINSON, M.D., PH.D.DRS. CONSTANCE CHU AND WILLIAM ROBINSON ARE CLINICIAN-SCIENTISTS WHOSE PROJECTS AT PAVIR REPRESENT TWO OF FIVE SYNERGISTIC PROJECTS INTEGRATING COMPLEX INTERACTIONS BETWEEN MECHANICAL, BIOLOGICAL, AND STRUCTURAL FACTORS TO PROVIDE INSIGHTS INTO THE PATHOGENESIS OF POST-TRAUMATIC OSTEOARTHRITIS (PTOA). THIS INTEGRATED PROGRAM EVALUATES AND OPTIMIZES NOVEL DIAGNOSTIC AND THERAPEUTIC STRATEGIES POISED FOR TRANSLATION INTO CLINICAL PRACTICE AND CONTRIBUTE NEW BIOMARKER, IMAGING AND THERAPEUTIC TARGETS FOR EARLY DETECTION AND STAGING OF JOIN DEGENERATION LEADING TO PTOA. PROJECT 1 DEFINES THE ROLE OF FIBRINOLYSIS IN THE DEVELOPMENT OF PTOA. THIS PROJECT EXAMINES THE HYPOTHESIS THAT DEREGULATION OF THE FIBRINOLYSIS SYSTEM DRIVES THE PATHOGENESIS OF PTOA BY PROMOTING INFLAMMATION AND CARTILAGE DEGRADATION. OBJECTIVES 1: PERFORM ELISA AND LUMINEX ASSAYS ON THE ANTERIOR CRUCIATE TEAR AND DEGENERATIVE MENISCAL TEAR CLINICAL COHORTS. 2: SURGICALLY INDUCE OA IN MICE AND ADMINISTER TRANEXAMIC ACID TREATMENT. 3: DESIGN AND PERFORM TRANEXAMIC ACID TREATMENT ON MICE SUBJECTED TO MOUSE OA. ACCOMPLISHMENTS: 1: THE RESEARCHERS IDENTIFIED DYSREGULATED TYPE II INFLAMMATORY MEDIATORS IN HUMAN PATIENTS WITH ACL AND DEGENERATIVE MENISCAL TEARS. 2: THE RESEARCH SHOWS THAT TRANEXAMIC ACID PREVENTS DEVELOPMENT OF OA. 3: THE RESEARCH SHOWS SOME BENEFIT OF TRANEXAMIC ACID TREATMENT WHEN TREATMENT IS STARTED 4 WEEKS AFTER JOINT INJURY, AND INCREASED BENEFIT WHEN STARTED 2 WEEKS AFTER SURGICAL JOINT INJURY.STATISTICAL TESTS ARE PERFORMED ON ALL EXPERIMENTAL DATA AND INCLUDE SIGNIFICANCE ANALYSIS OF MICROARRAYS (SAM) ANALYSIS OF MULTIPLEX CYTOKINE DATASETS (WHICH P < 0.05) AS WELL AS MANN WHITNEY TEST FOR MOUSE DATASETS (P<0.05 FOR KEY COMPARISONS).PROJECT 2 IS AN EARLY PHASE II DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO TEST THE HYPOTHESIS THAT TRANEXAMIC ACID AFTER JOINT INJURY WILL REDUCE MARKERS OF INFLAMMATION AND CARTILAGE DEGRADATION. IT WILL PROVIDE SCIENTIFIC GUIDANCE ON ANTERIOR CRUCIATE LIGAMENT TEAR (ACLT) SURGERY, CLINICAL OUTCOMES, AND ANALYSIS OF THE DATASETS. OBJECTIVES 1: DISCOVER THE DIFFERENCES IN SYNOVIAL FLUID LEVELS OF INFLAMMATORY & CARTILAGE BIOMARKERS. 2: TEST THE CELLS-BASED THERAPY IN ACL REGENERATION. 3: DISCOVER THE CHANGES IN BIOMARKERS IN CORRELATION WITH CARTILAGE HEALTH AFTER GAIT RE-TRAINING.ACCOMPLISHMENTS: 20 PATIENTS WITH ACUTE ACL WERE ENROLLED AND THEIR SAMPLES WERE COLLECTED AT THREE TIME POINTS. SAMPLES WILL BE ASSAYED FOR INFLAMMATORY FACTORS AND CYTOKINES. ANIMAL EXPERIMENTS WITH ACLT SURGERY HAVE BEEN CONDUCTED FOR THE FIRST 10 RATS. WE ARE IN THE PROCESS OF DOING THE NEXT 10 RATS TO DATE.WE WILL ENROLL AND COLLECT 50 PATIENTS' SAMPLES TO BE IN A LARGER COHORT AND ASSAY THE CYTOKINES IN WHOLE SET. THIS WAY, THE RESEARCH WILL GET ENOUGH STATISTICAL POWER TO CONCLUDE. STATICAL ANALYSIS BY A STATISTICIAN WILL BE PERFORMED ONCE OUR RECRUITMENT GOAL BASED ON A PRIORI POWER ANALYSIS IS REACHED. CURRENTLY, THE RESEARCHERS ARE RAMPING UP RECRUITMENT AND STRIVING TO COMPLETE DATA COLLECTION AND PROCESSING.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$732,930ExpenseAmt
DescANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC. PRINCIPAL INVESTIGATOR: DAVID A. RELMAN, M.D.ANTIMICROBIAL RESISTANCE (AMR) IS AN INCREASINGLY PREVALENT AND SERIOUS PROBLEM WORLDWIDE. THE HUMAN GUT IS A HOTSPOT FOR BOTH THE EVOLUTION AND SPREAD OF AMR; COMMENSALS SERVE AS A SOURCE OF AMR FOR PATHOGENS VIA HORIZONTAL GUT TRANSFER (HGT). WE ARE STUDYING RESPONSES TO ANTIBIOTIC EXPOSURE IN THE HUMAN GUT MICROBIOTA IN VIVO, AS WELL AS IN COMPLEX STOOL-DERIVED SUBJECT-SPECIFIC COMMUNITIES IN VITRO, AT HIGH TEMPORAL RESOLUTION AND USING INNOVATIVE APPROACHES. WE LINK AMR AND OTHER MOBILE GENETIC ELEMENT (MGE)-ASSOCIATED GENES TO THEIR HOST CORE GENOMES USING HIGH THROUGHOUT CHROMOSOME CONFORMATION CAPTURE (HI-C) AND MONITOR THESE GENES AND ELEMENTS IN BACTERIAL HOSTS BEFORE, DURING AND AFTER ANTIBIOTIC EXPOSURE. THE SHORT TERM-OBJECTIVES OF THE PROPOSED WORK ARE TO CHARACTERIZE AND ASSESS THE CONTRIBUTIONS OF DE NOVO MUTATIONS AND HGT TO THE SPREAD AND DEVELOPMENT OF AMR IN THE HUMAN GUT MICROBIOTA DURING ANTIBIOTIC EXPOSURE. THE LONG-TERM OBJECTIVES ARE TO IMPROVE ANTIBIOTIC STEWARDSHIP BY IDENTIFYING CRITICAL EVENTS OR TRANSITIONS IN THE EVOLUTION AND DISSEMINATION OF AMR IN VIVO, AND THE FACTORS AND CONDITIONS THAT MAKE THOSE EVENTS LESS LIKELY.OBJECTIVES - 1. DETERMINE THE DISTRIBUTION OF AMR GENES IN THE GUT MICROBIOTA OF 60 HEALTHY HUMANS PRIOR TO A CIPROFLOXACIN EXPOSURE . 2. CHARACTERIZE THE EFFECTS OF CIPROFLOXACIN ON THE ABUNDANCE AND MOBILIZATION OF AMR GENES IN THE HUMAN GUT MICROBIOTA IN VIVO FROM THE SAME 60 SUBJECTS DURING AND AFTER THE CIPROFLOXACIN EXPOSURE. 3. CHARACTERIZE THE EFFECTS OF CIPROFLOXACIN ON THE MOBILIZATION OF AMR GENES IN SYNTHETIC, HUMAN GUT-DERIVED MICROBIAL COMMUNITIES IN VITRO. WE ARE PROPAGATING PRE-EXPOSURE FECAL COMMUNITIES EX VIVO FROM ALL 60 SUBJECTS, AS WELL AS GENERATING COMPLEX, SYNTHETIC COMMUNITIES FROM PRE-EXPOSURE SAMPLES OF 5 SUBJECTS, AND THEN PASSAGING BOTH BULK AND SYNTHETIC COMMUNITIES ANAEROBICALLY UNDER MULTIPLE CIPROFLOXACIN REGIMES. WE ARE IDENTIFYING FACTORS AND CONDITIONS THAT AFFECT EMERGENCE OF AMR THROUGH HGT AND DE NOVO MUTATIONS IN VITRO.ACCOMPLISHMENTS: 1. STOOL SAMPLES FROM 60 SUBJECTS WERE EXTRACTED AND SEQUENCED. 2. HI-C DNA LIBRARIES ARE BEING CONSISTENTLY GENERATED. NEW COMPUTATIONAL APPROACHES HAVE BEEN DEVELOPED THAT WORK DIRECTLY FROM METAGENOMIC DATA TO RECOVER EXTRA-CHROMOSAL MGES (ECMGES). A NEW TOOL FOR RECONSTRUCTING ECMGE GENOMES FROM METAGENOMIC DATA WAS CREATED. 3. FACS SORTING APPROACH FOR OBTAINING GUT ISOLATES HAS BEEN DRAMATICALLY IMPROVED. SYSTEMATIC STUDY OF NUTRIENT AVAILABILITY AND COMMUNITY COMPOSITION PROVIDES A PREDICTIVE FRAMEWORK THAT WILL AID IN RATIONAL DESIGN OF COMMUNITIES FOR STUDYING HGT OF AMR GENES AND HAS ESTABLISHED THE LAB'S ABILITY TO MODEL VARIOUS HUMAN FECAL SAMPLES WITH COMMUNITIES IN VITRO.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$20,244,621ExpenseAmt
Revenue$3,221,296RevenueAmt
DescPAVIR IS PRIVILEGED TO WORK WITH A LARGE COMMUNITY OF UNIQUELY TALENTED MEDICAL RESEARCHERS ACROSS A BROAD SPECTRUM OF RESEARCH AREAS AS WE FULFILL OUR MISSION OF ADVANCING VETERANS AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH. THE RANGE OF RESEARCH ACTIVITIES IS BROAD AND INCLUDES SPECIAL EMPHASIS ON MAJOR DISEASE CATEGORIES, ALL OF WHICH ARE PREVALENT IN THE VA'S PATIENT POPULATION. THESE INCLUDE CARDIOVASCULAR MEDICINE, MENTAL HEALTH, CHRONIC INFLAMMATORY DISEASE, STEM CELL/REGENERATIVE MEDICINE, PAIN, SLEEP DISORDERS, AND MANY OTHERS. IN ADDITION TO DISEASE SPECIFIC RESEARCH, PAVIR IS ENGAGED IN SUPPORTING RESEARCH AIMED AT ENHANCING HEALTH CARE. PAVIR'S RESEARCH PORTFOLIO INCLUDES COMPARATIVE STUDIES IN WHICH RESEARCH TEAMS ARE LEARNING WHICH TREATMENTS ARE SUPERIOR TO OTHERS, HOW TO AUGMENT OR IMPROVE STANDARD OF CARE, AS WELL AS HOW TO ENHANCE THE OPERATION OF HEALTH CARE. FURTHERMORE, PAVIR IS SUPPORTING EDUCATIONAL ACTIVITIES, ESPECIALLY IN AREAS OF ADVANCING CLINICAL CARE FOR VETERANS AND FOSTERING THE PROFESSIONAL DEVELOPMENT OF OUR EXPERT STAFF.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$20,244,621TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$3,221,296TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$23,433,313TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document44IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee273EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (1)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonLILY IBRAGIMOVPersonNm
Phone6502392805PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line13801 MIRANDA AVENUEAddressLine1Txt
CityPALO ALTOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94304ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
LISA HOWARD
STATUTORY VA DIRECTOR0.5040.00Yes (X)$0$0$0
MEGHAN KEMNEC ND
STATUTORY NON-VA DIRECTOR0.50Yes (X)$0$0$0
MIKE KOZAL MD
STATUTORY VA DIRECTOR0.5040.00Yes (X)$0$0$0
PAUL HEIDENREICH
DIRECTOR, SECRETARY/TREASURER1.0040.00Yes (X)$0$0$0Yes (X)
LAWRENCE LEUNG
DIRECTOR/AUDIT COMMITTEE CHAIR1.0040.00Yes (X)$0$0$0
DAVID J CLARK
DIRECTOR, BOARD CHAIR1.0040.00Yes (X)$0$0$0Yes (X)
ODETTE HARRIS MD MPH
DIRECTOR UNTIL 8/31/210.5040.00Yes (X)$0$0$0
ANDREW R HOFFMAN MD
DIRECTOR0.5040.00Yes (X)$0$0$0
PHILIP TSAO
DIRECTOR1.0040.00Yes (X)$0$0$0
MARK NICOLLS
DIRECTOR1.0040.00Yes (X)$0$0$0
FERID MURAD
DIRECTOR0.50Yes (X)$47,492$0$4,274
JOHN POLLARD
STATUTORY VA DIRECTOR0.5040.00Yes (X)$0$0$0
ROBERT SLOSS
STATUTORY NON-VA DIRECTOR0.50Yes (X)$0$0$0
JENNIFER LEE
STATUTORY VA DIRECTOR1.0040.00Yes (X)$0$0$0
THOMAS J FITZGERALD III
STATUTORY VA DIRECTOR UNTIL 1/31/210.5040.00Yes (X)$0$0$0
RINA N SHAH
STATUTORY VA DIRECTOR UNTIL 2/28/210.5040.00Yes (X)$0$0$0
CHARLIE CONZ
STATUTORY NON-VA DIR. UNTIL 01/13/210.50Yes (X)$0$0$0
MICHAEL ANTHONY HINDERY
CEO UNTIL 9/1/2140.00$286,211$0$37,458Yes (X)
LISA CLARK
HR DIRECTOR40.00$171,978$0$16,561Yes (X)
LILY IBRAGIMOV
DIRECTOR OF FINANCE & ACCOUNTING40.00$160,590$0$25,599Yes (X)
ELAINE STAATS
DIRECTOR OF SPONSORED RESEARCH40.00$154,949$0$35,730Yes (X)
WEN AMY TIAN
RESEARCH SCIENTIST II40.00$147,369$0$11,520Yes (X)
MARY L THORNTON
DIRECTOR OF DATA INTEGRITY40.00$144,762$0$24,132Yes (X)
MAHEEN ADAMSON
PRINCIPAL INVESTIGATOR II40.00$142,984$0$13,074Yes (X)
XINGUO JIANG
RESEARCH SCIENTIST II40.00$139,412$0$31,039Yes (X)
CUIPING PAN
BUSINESS DEVELOPMENT MANAGER III40.00$137,430$0$13,880Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,533,177TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$213,267TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K9IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Government Grants$22,643,899GovernmentGrantsAmt
All Other Contributions$1,826,456AllOtherContributionsAmt
Total Contributions$24,470,355TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
GOVERNMENT FEES & CONTRACTS541700$2,591,113$2,591,113
MEDICAL RESEARCH541700$2,285,785$2,285,785
FieldValueIRS element (for citing)
Total Program Service Revenue$4,876,898TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$17,582TotalRevenueColumnAmt
Exclusion$17,582ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Other$66,941OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Other$67,564OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Other-$623OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$623TotalRevenueColumnAmt
Exclusion-$623ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUS INCOMEDesc
Business900099BusinessCd
Total Revenue Column$35,800TotalRevenueColumnAmt
Exclusion$35,800ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$35,800OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$29,400,012TotalRevenueColumnAmt
Related Or Exempt Func Income$4,876,898RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$52,759ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$968,578TotalAmt
Program Services$51,766ProgramServicesAmt
Management And General$916,812ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$12,179,694TotalAmt
Program Services$9,666,107ProgramServicesAmt
Management And General$2,513,587ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$821,621TotalAmt
Program Services$633,446ProgramServicesAmt
Management And General$188,175ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,059,383TotalAmt
Program Services$842,531ProgramServicesAmt
Management And General$216,852ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,024,361TotalAmt
Program Services$773,352ProgramServicesAmt
Management And General$251,009ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$42,537TotalAmt
Program Services$9,164ProgramServicesAmt
Management And General$33,373ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$87,911TotalAmt
Management And General$87,911ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,122,648TotalAmt
Program Services$1,050,898ProgramServicesAmt
Management And General$71,750ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$23,123TotalAmt
Program Services$20,508ProgramServicesAmt
Management And General$2,615ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$523,237TotalAmt
Program Services$325,984ProgramServicesAmt
Management And General$197,253ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$28,544TotalAmt
Program Services$28,544ProgramServicesAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$7,292TotalAmt
Program Services$7,292ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$202,833TotalAmt
Program Services$172,610ProgramServicesAmt
Management And General$30,223ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$273,587TotalAmt
Program Services$258,434ProgramServicesAmt
Management And General$15,153ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$56,345TotalAmt
Management And General$56,345ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
SUBRECIPIENTS$3,953,428$3,953,428
RESEARCH MATERIAL COST$2,774,868$2,774,868
OTHER PERSONNEL COST$2,694,507$2,610,405$84,102
EQUIPMENT MAINTENANCE$180,449$179,098$1,351

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$93,995TotalAmt
Program Services$74,878ProgramServicesAmt
Management And General$19,117ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$28,118,941TotalAmt
Program Services$23,433,313ProgramServicesAmt
Management And General$4,685,628ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,823,799BOYAmt
EOY$1,418,346EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,999,388BOYAmt
EOY$9,417,233EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,029,336BOYAmt
EOY$3,294,258EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$214,129BOYAmt
EOY$268,015EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$3,952,069LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$3,159,948LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$915,754BOYAmt
EOY$792,121EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$12,982,406BOYAmt
EOY$15,189,973EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,155,963BOYAmt
EOY$3,789,802EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$1,409,314BOYAmt
EOY$3,389,862EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$700,000BOYAmt
EOY$11,482EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$6,265,277BOYAmt
EOY$7,191,146EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,271,449BOYAmt
EOY$5,040,085EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,445,680BOYAmt
EOY$2,958,742EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$6,717,129BOYAmt
EOY$7,998,827EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,982,406BOYAmt
EOY$15,189,973EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,281,071ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$627NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1VA PALO ALTO HEALTH CARE SYSTEMBusinessNameLine1Txt
FieldValueIRS element (for citing)
CityPALO ALTOCityNm
State AbbreviationCAStateAbbreviationCd

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,952,069OtherCostOrOtherBasisAmt
Depreciation$3,159,948DepreciationAmt
Book Value$792,121BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$792,121TotalBookValueLandBuildingsAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$29,400,639TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$627NetUnrealizedGainsInvstAmt
Revenue Not Reported$627RevenueNotReportedAmt
Revenue Subtotal$29,400,012RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$29,400,012TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$28,118,941TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$28,118,941ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$28,118,941TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION IS A NONPROFIT CORPORATION EXEMPT FROM FEDERAL INCOME TAX UNDER INTERNAL REVENUE CODE SECTION 501(C)(3) AND STATE INCOME TAX UNDER CALIFORNIA REVENUE AND TAXATION CODE SECTION 23701D. HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER IRC SECTION 170(B)(1)(A)(III) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A)(1). AS OF SEPTEMBER 30, 2021 AND 2020, THE ORGANIZATION HAD NO UNRECOGNIZED TAX BENEFITS OR UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL. THEREFORE, NO PROVISION FOR INCOME TAXES HAS BEEN PROVIDED IN THE FINANCIAL STATEMENTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MICHAEL ANTHONY HINDERY
CEO UNTIL 9/1/21$286,211$0$0$0$0$0$25,650$0$11,808$0$323,669$0$0$0
ELAINE STAATS
DIRECTOR OF SPONSORED RESEARCH$154,949$0$0$0$0$0$15,203$0$20,527$0$190,679$0$0$0
LISA CLARK
HR DIRECTOR$171,978$0$0$0$0$0$15,494$0$1,067$0$188,539$0$0$0
LILY IBRAGIMOV
DIRECTOR OF FINANCE & ACCOUNTING$160,590$0$0$0$0$0$14,819$0$10,780$0$186,189$0$0$0
XINGUO JIANG
RESEARCH SCIENTIST II$139,412$0$0$0$0$0$13,270$0$17,769$0$170,451$0$0$0
MARY L THORNTON
DIRECTOR OF DATA INTEGRITY$144,762$0$0$0$0$0$13,394$0$10,738$0$168,894$0$0$0
WEN AMY TIAN
RESEARCH SCIENTIST II$147,369$0$0$0$0$0$11,026$0$494$0$158,889$0$0$0
MAHEEN ADAMSON
PRINCIPAL INVESTIGATOR II$142,984$0$0$0$0$0$9,173$0$3,901$0$156,058$0$0$0
CUIPING PAN
BUSINESS DEVELOPMENT MANAGER III$137,430$0$0$0$0$0$12,420$0$1,460$0$151,310$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 7APAVIR IS A NONPROFIT CORPORATION AUTHORIZED BY TITLE 38 US CODE SECTIONS 7361 THROUGH 7366 TO BE ESTABLISHED AT AND AFFILIATED WITH THE DEPARTMENT OF VETERANS AFFAIRS PALO ALTO HEALTH CARE SYSTEM (VAPAHCS). THE REFERENCED STATUTE DICTATES THAT FOUR DIRECTORS SHALL BE THOSE PERSONS HOLDING THE VAPAHCS POSITIONS OF DIRECTOR, CHIEF OF STAFF, ASSOCIATE CHIEF OF STAFF FOR RESEARCH AND ASSOCIATE CHIEF OF STAFF FOR EDUCATION.
FORM 990, PART VI, SECTION A, LINE 7BAS STATED IN RESPONSE TO FORM 990, PART VI, LINE 7A ABOVE, VA HAS AUTHORITY TO IMPOSE REQUIREMENTS AND RESTRICTIONS ON THE ORGANIZATION THROUGH THE REFERENCED STATUTE AND REGULATIONS PRESCRIBED BY THE SECRETARY OF VETERANS AFFAIRS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 HAS BEEN PROVIDED TO ALL BOARD MEMBERS FOR THEIR REVIEW PRIOR TO THE FILING OF RELATED TAX FORMS.
FORM 990, PART VI, SECTION B, LINE 12CDIRECTORS, OFFICERS AND KEY EMPLOYEES COMPLETE TRAINING IN AND ATTEST TO COMPLIANCE WITH PAVIR'S CONFLICT OF INTEREST POLICY, AS WELL AS DISCLOSING INTERESTS WHICH COULD GIVE RISE TO CONFLICTS, UPON JOINING PAVIR AND ANNUALLY THEREAFTER. MANAGEMENT TRACKS THE DATES, SENDS REMINDERS AND DOCUMENTS RECEIPT OF TRAINING, ATTESTATIONS, AND DISCLOSURES, ASSURING COMPLIANCE IN EACH CALENDAR YEAR.
FORM 990, PART VI, SECTION B, LINE 15ANNUALLY, PAVIR COLLECTS AND ANALYZES MARKET, SALARY SURVEY AND COMPENSATION STUDY DATA BASED ON COMPARABLE INDUSTRY AND REVENUE. THE BOARD'S COMPENSATION COMMITTEE REVIEWS THE DATA, TAKING INTO ACCOUNT PERFORMANCE AND ACCOMPLISHMENTS WHEN ESTABLISHING THE CEO'S COMPENSATION. THE COMPENSATION COMMITTEE KEEPS MINUTES OF ITS MEETINGS AND REPORTS ITS ACTIONS TO THE FULL BOARD. KEY EMPLOYEES' SALARIES ARE SET BY THE CEO UTILIZING INFORMATION FROM PAVIR'S ANNUAL SALARY SCHEDULES.
FORM 990, PART VI, SECTION C, LINE 19THE AUDITED FINANCIAL STATEMENTS, ORGANIZING/GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON WRITTEN REQUEST.
FORM 990, PART VII AND SCHEDULE J, PART II:ON 03/07/22, THE CEO WROTE TO EACH OF THE 13 BOARD MEMBERS WHO ARE COMPENSATED BY THE VA PALO ALTO HEALTH CARE SYSTEM REQUESTING PERMISSION TO OBTAIN HIS/HER COMPENSATION INFORMATION FOR THE TAX YEAR ENDING 12/31/20. IN RESPONSE, ALL BOARD MEMBERS DECLINED IN WRITING TO PROVIDE THEIR COMPENSATION INFORMATION. NONE OF THE BOARD MEMBERS RECEIVE COMPENSATION IN RELATION TO THEIR DUTIES AS BOARD MEMBERS OF PAVIR.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1VA PALO ALTO HEALTH CARE SYSTEMBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line13801 MIRANDA AVENUEAddressLine1Txt
CityPALO ALTOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94304ZIPCd
FieldValueIRS element (for citing)
EIN941179505EIN
Primary ActivitiesTEACHING HOSPITAL, PROVIDING A FULL RANGE OF PATEINT CARE SERVICESPrimaryActivitiesTxt
Legal Domicile StateCALegalDomicileStateCd
Exempt Code Section501(C)(1)ExemptCodeSectionTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (1)PerformOfServicesForOthOrgInd
Perform Of Services By Other OrgYes (1)PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (1)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd